Related Experiment Video
Updated: Feb 9, 2026

A G-quadruplex DNA-affinity Approach for Purification of Enzymatically Active G4 Resolvase1
Published on: March 18, 2017
An anionic phthalocyanine decreases NRAS expression by breaking down its RNA G-quadruplex
Keiko Kawauchi1, Wataru Sugimoto2, Takatoshi Yasui2
1Faculty of Frontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, 650-0047, Japan. kawauchi@center.konan-u.ac.jp.
Researchers developed ZnAPC, a photosensitizer that targets NRAS mRNA. Photo-irradiation with ZnAPC selectively degrades NRAS mRNA, reducing cancer cell viability, offering a new approach for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Aberrant RAS signaling pathways drive aggressive cancer phenotypes.
- RAS-targeted therapies show promise but face challenges due to RAS protein structural complexity.
- NRAS is a key RAS isoform implicated in cancer progression.
Purpose of the Study:
- To investigate the potential of ZnAPC, an anionic phthalocyanine, to control NRAS expression via photo-irradiation.
- To explore ZnAPC's mechanism of targeting NRAS mRNA for therapeutic intervention.
- To evaluate the efficacy of ZnAPC-mediated photodynamic therapy in reducing cancer cell viability.
Main Methods:
- In vitro binding assays of ZnAPC with NRAS mRNA G-quadruplex structures.
- Assessment of ZnAPC's selectivity for NRAS mRNA G-quadruplexes in the presence of cellular RNA.
- Photo-irradiation experiments to induce selective RNA cleavage and assess downstream effects.
- Measurement of NRAS mRNA and protein levels following ZnAPC treatment and photo-irradiation.
- Evaluation of cancer cell viability after treatment.
Main Results:
- ZnAPC selectively binds to a G-quadruplex-forming oligonucleotide in the 5'-untranslated region of NRAS mRNA.
- ZnAPC binding and subsequent photo-irradiation lead to selective cleavage of the target NRAS mRNA G-quadruplex.
- Photo-irradiation with ZnAPC significantly decreases NRAS mRNA and NRAS protein expression in cancer cells.
- Reduced NRAS expression resulted in decreased cancer cell viability.
Conclusions:
- ZnAPC acts as a photosensitizer to control NRAS expression by targeting its mRNA.
- The selective binding and photo-cleavage mechanism offers a novel approach to RAS-targeted cancer therapy.
- ZnAPC shows potential as a photosensitizer for molecularly targeted photodynamic therapy against cancers driven by NRAS.
Related Concept Videos
Decreasing Function
Fixing Double-strand Breaks
Fixing Double-strand Breaks
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
RNA Stability

